CME Group launches first index-based hockey futures on Sept 28

scanx
Reviewed by
Ritika DScanX News Team
Key Highlights

CME Group is set to introduce the world's first index-based hockey futures on September 28, pending regulatory approval. The contracts, available in standard and micro sizes, will track CME FutureSports Performance Indexes using real-time NHL statistics from the 2026-2027 season onward. This launch expands the derivatives marketplace into sports performance metrics, offering regulated financial instruments linked to official league data.

powered bylight_fuzz_icon
48027375

*this image is generated using AI for illustrative purposes only.

CME Group, the world's leading derivatives marketplace, announced on August 11, 2026, that it will launch the world's first index-based hockey futures contracts on September 28. This product launch marks a significant expansion into sports-linked derivatives, offering investors exposure to professional hockey performance through standardized financial instruments rather than traditional betting markets.

The new contracts are subject to regulatory review before their scheduled debut. CME Group confirmed that both standard-sized and micro-sized contracts will be available to traders, providing flexibility for different levels of capital commitment and risk management strategies.

Contract Specifications and Data Source

The futures contracts will be benchmarked to official National Hockey League (NHL) statistics. Specifically, they will track CME FutureSports Performance Indexes, which utilize exclusive, real-time data feeds from the NHL. This integration ensures that contract settlements are based on accurate, official league statistics rather than third-party approximations.

Feature Detail
Product Type Index-based Hockey Futures
Contract Sizes Standard-sized and Micro-sized
Benchmark CME FutureSports Performance Indexes
Data Source Official NHL Statistics (Real-time)
Launch Date September 28 (Pending Regulatory Review)
Season Coverage Beginning with 2026-2027 season

Strategic Implications

The introduction of these contracts represents a novel approach to sports finance, bridging the gap between fan engagement and financial derivatives. By leveraging real-time NHL statistics, CME Group aims to provide a transparent and regulated avenue for trading hockey performance metrics. The inclusion of micro-sized contracts lowers the barrier to entry, potentially attracting a broader base of retail and institutional participants interested in sports-related assets.

What the Numbers Show

While specific trading volumes or notional values were not disclosed in the announcement, the structural design of the products highlights a focus on accessibility and data integrity. The dual offering of standard and micro contracts suggests an expectation of diverse participant interest, ranging from large institutional hedgers to smaller speculative traders. The reliance on official NHL statistics mitigates the operational risks often associated with event-driven derivatives, ensuring that settlement disputes are minimized through authoritative data sources.

How might the introduction of micro-sized hockey futures contracts influence retail investor participation in sports-linked derivatives compared to traditional betting markets?

What regulatory hurdles could potentially delay or alter the September 28 launch date, and how might these affect initial trading volumes?

Could the success of CME's hockey futures model accelerate the development of similar index-based derivatives for other major North American sports leagues?

like18
dislike

CME Group shares surge 6.7% on upbeat Q2 earnings

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights

CME Group reported second-quarter adjusted EPS of $2.99 on revenue of $1.706 billion, surpassing analyst estimates. The company achieved record H1 performance with net income of $2.2 billion and returned $1.16 billion to shareholders via dividends and buybacks.

powered bylight_fuzz_icon
46270596

*this image is generated using AI for illustrative purposes only.

CME Group Inc. shares rose 6.7% to $253.29 on Wednesday after the company reported second-quarter earnings that exceeded market expectations. For the quarter ended June 30, 2026, CME posted adjusted earnings per share of $2.99, beating analyst estimates of $2.91. The company’s quarterly sales totaled $1.706 billion, topping expectations of $1.685 billion.

Financial Performance

Revenue for the second quarter of 2026 totaled $1.7 billion, compared to $1.7 billion in the prior year period. Operating income was $1.1 billion, while adjusted operating income reached $1.2 billion. Net income attributable to common shareholders was $1.0 billion, or $2.88 per diluted share on a GAAP basis. On an adjusted basis, net income was $1.1 billion, or $2.99 per diluted share.

For the six months ended June 30, 2026, total revenue increased to $3.6 billion from $3.3 billion in the prior year. Net income for the first half rose to $2.2 billion from $2.0 billion. Adjusted net income for the six-month period was $2.3 billion, with adjusted diluted earnings per share of $6.35.

Operational Metrics

Second-quarter 2026 average daily volume (ADV) reached 29.8 million contracts, the third highest quarterly ADV in the company's history. This included non-U.S. ADV of 9.1 million contracts. Clearing and transaction fees revenue totaled $1.4 billion, with an average rate per contract of $0.678. Market data revenue increased 20% to a record $238 million.

Capital Allocation

As of June 30, 2026, CME Group held $2.3 billion in cash and $3.4 billion of debt. During the second quarter, the company returned capital to shareholders through dividends of approximately $468 million and share repurchases totaling $695 million.

Metric Q2 2026 Q2 2025 Change
Revenue $1.7 billion $1.7 billion Stable
Net Income $1.0 billion $1.0 billion Stable
Adjusted Net Income $1.1 billion $1.1 billion Stable
Diluted EPS (Adj.) $2.99 $2.96 Increase
ADV (millions) 29.8 30.2 Decrease
Market Data Revenue $238 million $198 million Increase

Strategic Developments

CME Group Chairman and Chief Executive Officer Terry Duffy highlighted the company's continued innovation, including the introduction of Single-Stock futures, 1-Ounce Gold contracts available 24/7, U.S. Treasury clearing, and Compute futures. The company noted that the first half of 2026 was the strongest in its history, with record H1 performance across revenue, adjusted operating income, adjusted net income, and adjusted earnings per share.

How will the introduction of Single-Stock futures and Compute futures impact CME's competitive position in the derivatives market?

Can the 20% growth in Market Data revenue be sustained as demand for real-time analytics evolves?

What is the outlook for Average Daily Volume (ADV) given the slight decline compared to the prior year?

like16
dislike

More News on CME Group Inc